Search Count: 22
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.49 Å Release Date: 2021-11-17 Classification: TRANSFERASE/Transcription Ligands: ZR1 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.71 Å Release Date: 2021-11-17 Classification: Transferase/Transcription Ligands: ZR4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.41 Å Release Date: 2021-11-17 Classification: TRANSFERASE/Transcription Ligands: ADN |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2021-11-17 Classification: TRANSFERASE/Transcription Ligands: ZR4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.55 Å Release Date: 2021-11-17 Classification: transferase/Transcription Ligands: ZR1 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2018-06-27 Classification: TRANSFERASE |
 |
Structure Of The Ptk6 Kinase Domain Bound To A Type I Inhibitor (3-Fluoro-4-{[6-Methyl-3-(1H-Pyrazol-4-Yl)Imidazo[1,2-A]Pyrazin-8-Yl]Amino}Phenyl)(Morpholin-4-Yl)Methanone
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2018-06-20 Classification: Transferase/Transferase Inhibitor Ligands: FLJ, ACT, K |
 |
Structure Of The Ptk6 Kinase Domain Bound To A Type Ii Inhibitor 2-{[(3R,4S)-3-Fluoro-1-{[4-(Trifluoromethoxy)Phenyl]Acetyl}Piperidin-4-Yl]Oxy}-5-(1-Methyl-1H-Imidazol-4-Yl)Pyridine-3-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2018-06-20 Classification: Transferase/Transferase Inhibitor Ligands: FKY |
 |
Crystal Structure Of Human Set And Mynd Domain Containing Protein 2 With Mtf1497
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2018-03-14 Classification: TRANSFERASE/INHIBITOR Ligands: ZN, EW1, CL, EDO, UNX |
 |
Crystal Structure Of Human Set And Mynd Domain Containing Protein 2 With Mtf9975
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.55 Å Release Date: 2018-03-14 Classification: TRANSFERASE/INHIBITOR Ligands: ZN, EW4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.02 Å Release Date: 2017-08-02 Classification: TRANSFERASE Ligands: ZN, A4M, DMS, TRS, UNX |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2016-05-25 Classification: PROTEIN BINDING |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2013-04-17 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: SAM, 1L8, UNX |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2013-03-27 Classification: transferase/transferase inhibitor Ligands: SAM, 1L4, UNX |
 |
Set7/9 In Complex With Inhibitor (R)-(3-(3-Cyanophenyl)-1-Oxo-1-(Pyrrolidin-1-Yl)Propan-2-Yl)-1,2,3,4-Tetrahydroisoquinoline-6- Sulfonamide And S-Adenosylmethionine
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2012-03-28 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: SAM, 0N6, BME, SO4 |
 |
Optimization Of Potent, Selective, And Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors Of Heat Shock Protein 90. Identification Of Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-Fluoro-1H-Pyrazol-1-Yl)Ethoxy]-6-Methylphenyl}-N-(2,2-Difluoropropyl)-5,7-Dihydro-6H-Pyrrolo[3,4-D]Pyrimidine-6-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2011-04-27 Classification: Chaperone/Chaperone inhibitor Ligands: WOE |
 |
Optimization Of Potent, Selective, And Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors Of Heat Shock Protein 90. Identification Of Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-Fluoro-1H-Pyrazol-1-Yl)Ethoxy]-6-Methylphenyl}-N-(2,2-Difluoropropyl)-5,7-Dihydro-6H-Pyrrolo[3,4-D]Pyrimidine-6-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2011-04-27 Classification: Chaperone/Chaperone inhibitor Ligands: FU5 |
 |
Optimization Of Potent, Selective, And Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors Of Heat Shock Protein 90. Identification Of Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-Fluoro-1H-Pyrazol-1-Yl)Ethoxy]-6-Methylphenyl}-N-(2,2-Difluoropropyl)-5,7-Dihydro-6H-Pyrrolo[3,4-D]Pyrimidine-6-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2011-04-27 Classification: Chaperone/Chaperone inhibitor Ligands: FU3 |
 |
Optimization Of Potent, Selective, And Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors Of Heat Shock Protein 90. Identification Of Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-Fluoro-1H-Pyrazol-1-Yl)Ethoxy]-6-Methylphenyl}-N-(2,2-Difluoropropyl)-5,7-Dihydro-6H-Pyrrolo[3,4-D]Pyrimidine-6-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2011-04-27 Classification: Chaperone/Chaperone inhibitor Ligands: FU7, PO4 |
 |
Organism: Hepatitis c virus
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2009-03-10 Classification: TRANSFERASE Ligands: AG0, AG6, BME |